We are live on ! Find out more
WST icon

West Pharmaceutical
WST

197 hedge funds and large institutions have $2.19B invested in West Pharmaceutical in 2013 Q2 according to their latest regulatory filings, with 197 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

180.46% more ownership

Funds ownership: 0% → 180.46% (+180%)

Holders
197
Holders Change
+197
Holders Change %
–
% of All Funds
6.43%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
197
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$25.3M +$23.7M +721,266 New
KCM
27
Kennedy Capital Management
Missouri
$25.2M +$23.6M +717,232 New
BAMCO Inc
28
BAMCO Inc
New York
$22.8M +$21.3M +647,708 New
SM
29
Stratton Management
Pennsylvania
$22.2M +$20.8M +632,200 New
TI
30
Turner Investments
Pennsylvania
$21.8M +$20.5M +621,520 New
CRCP
31
Copper Rock Capital Partners
Massachusetts
$19.6M +$18.3M +557,392 New
Renaissance Technologies
32
Renaissance Technologies
New York
$16.3M +$15.3M +464,800 New
CB
33
Cooke & Bieler
Pennsylvania
$14.3M +$13.4M +406,002 New
Principal Financial Group
34
Principal Financial Group
Iowa
$13.6M +$12.8M +388,118 New
Norges Bank
35
Norges Bank
Norway
$12.3M +$11.5M +350,318 New
TCIM
36
TIAA CREF Investment Management
New York
$11.7M +$10.9M +332,512 New
Schroder Investment Management Group
37
Schroder Investment Management Group
United Kingdom
$11.7M +$10.9M +332,318 New
SAM
38
Sentinel Asset Management
Vermont
$11.6M +$10.9M +330,700 New
Prudential Financial
39
Prudential Financial
New Jersey
$11.5M +$10.8M +326,774 New
RIM
40
RS Investment Management
California
$11.4M +$10.7M +324,160 New
Geode Capital Management
41
Geode Capital Management
Massachusetts
$11.3M +$10.6M +322,482 New
KeyBank National Association
42
KeyBank National Association
Ohio
$10.6M +$9.92M +301,406 New
PI
43
Putnam Investments
Massachusetts
$9.94M +$9.31M +283,000 New
RCM
44
Rutabaga Capital Management
Massachusetts
$9.6M +$8.99M +273,296 New
CCM
45
Century Capital Management
Massachusetts
$9.46M +$8.86M +269,228 New
CII
46
CR Intrinsic Investors
Connecticut
$8.78M +$8.23M +250,000 New
MAA
47
Managed Account Advisors
New Jersey
$8.76M +$8.21M +249,444 New
NTCOC
48
Northern Trust Company of Connecticut
Connecticut
$8.02M +$7.52M +228,420 New
EA
49
Emerald Advisers
Pennsylvania
$7.87M +$7.37M +224,090 New
BIM
50
BlackRock Investment Management
Delaware
$7.69M +$7.2M +218,918 New
1
2
3 4 5

WST Hedge Fund Activity: Q2 2013 in Review

197 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q2 2013, worth a combined $2.19B.

Buyers outnumbered sellers: 197 funds opened new WST positions and 0 closed out — a net gain of 197 holders — while 0 added to existing stakes and 0 trimmed.

  • 197 institutional investors held West Pharmaceutical (WST) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.19B of West Pharmaceutical stock for Q2 2013.
  • 197 funds opened new West Pharmaceutical positions in Q2 2013 and 0 closed out, a net change of +197 holders.

Based on aggregated 13F filings for Q2 2013.